FDA Approved: ERLEADA — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

FDA approved a supplemental application for ERLEADA (apalutamide) from Janssen Products, LP, indicating an expanded authorization for the drug’s labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ERLEADA (apalutamide)

Snippet

SUPPL AP for ERLEADA (APALUTAMIDE)